Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
11/03/2022* -- Results Q3 2022 -- 1.32 --
11/03/2022* 08:00 EST Earnings Call Q3 2022 -- -- --
08/02/2022 -- Results Q2 2022 1.25 1.19 4.63%
08/02/2022 09:00 EST Earnings Call Q2 2022 -- -- --
04/29/2022 -- Results Q1 2022 1.01 0.95 6.47%
04/29/2022 08:00 EST Earnings Call Q1 2022 -- -- --
02/17/2022 -- Results Q4 2021 1.48 1.43 3.33%
02/17/2022 08:00 EST Earnings Call Q4 2021 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 11/03/2022 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 08/02/2022
Beat/Miss Upgrade
Return Since -21.09%
Last FQE 06/30/2022
Next FQE 09/30/2022

Profile

Edit
Syneos is a global contract research and outsourced commercialization organization that provides services to pharmaceutical and biotechnology firms. Its clinical solutions segment offers early- to late-stage clinical trial support that ranges from specialized staffing models to strategic partnerships that oversee nearly all aspects of a drug program, while the company’s commercialization solutions includes outsourced sales, consulting, public relations, and advertising services.
URL https://www.syneoshealth.com
Investor Relations URL https://www.investor.syneoshealth.com/
HQ State/Province North Carolina
Sector Healthcare
Industry Diagnostics & Research
Equity Style Small Cap/Blend
Next Earnings Release Nov. 03, 2022 (est.)
Last Earnings Release Aug. 02, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Dividends

Dividend Per Share (TTM) --
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.00
Yield to Sector 0.00
Yield to Industry 0.00
Last Dividend Amt. --
Dividend Frequency --
Last Ex-Dividend Date --
Yield (TTM) 0.00%
Forward Yield --
Payout Ratio 0.00%
Cash Payout Ratio 0.00%
Consistent Payer (5Y) No
Consistent Growth (5Y) No

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
88.83%
8.43%
-17.11%
-9.75%
51.14%
14.55%
50.71%
-49.89%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-19.50%
--
--
--
--
--
--
--
-70.94%
30.44%
-7.73%
51.19%
-4.04%
-12.02%
-6.93%
-27.66%
-36.99%
-1.64%
60.82%
33.35%
18.95%
40.38%
91.43%
31.73%
-47.06%
-8.79%
1.45%
17.86%
-13.31%
45.38%
3.76%
-17.02%
-11.52%
As of October 04, 2022.

Profile

Edit
Syneos is a global contract research and outsourced commercialization organization that provides services to pharmaceutical and biotechnology firms. Its clinical solutions segment offers early- to late-stage clinical trial support that ranges from specialized staffing models to strategic partnerships that oversee nearly all aspects of a drug program, while the company’s commercialization solutions includes outsourced sales, consulting, public relations, and advertising services.
URL https://www.syneoshealth.com
Investor Relations URL https://www.investor.syneoshealth.com/
HQ State/Province North Carolina
Sector Healthcare
Industry Diagnostics & Research
Equity Style Small Cap/Blend
Next Earnings Release Nov. 03, 2022 (est.)
Last Earnings Release Aug. 02, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
MFC8653 144.52M USD 3.53%
CBSCX 69.75M USD 2.99%
SMCPX 52.40M USD 2.64%
SCSMX 106.69M USD 2.57%
FSCRX 71.68M USD 2.49%
HQL 10.54M USD 2.16%
JSEQX 92.24M USD 1.51%
HQH 14.05M USD 1.38%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter SYNH Tweets